$AKBA 4 SEC Filings

Filed On	Filing
10 Aug 2026	Form 4: Butler John P., Director Received 350,000 shares by exercise or conversion ($221K)
01 Jul 2026	Form 4: Ostrowski Erik, SVP, CFO, CBO & Treasurer Sold 56,019 shares ($62.2K)
22 Jun 2026	Form 4: Wolf Myles, Director Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy)
22 Jun 2026	Form 4: Smith Cynthia, Director Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy)
22 Jun 2026	Form 4: Rogers Michael W, Director Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy)
22 Jun 2026	Form 4: Frieson Ron, Director Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy)
22 Jun 2026	Form 4: Zumwalt Leanne M, Director Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy)
22 Jun 2026	Form 4: Adams Adrian, Director Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy)
03 Apr 2026	Form 4: Vickers Philip J., Director Granted 214,400 Stock Option (Right to buy)
05 Mar 2026	Form 4: Butler John P., Director Bought 69,270 shares ($86.6K)
04 Feb 2026	Form 4: Grund Nicholas, Chief Commercial Officer Sold 84,829 shares ($118K)
04 Feb 2026	Form 4: Malabre Richard C, SVP, Chief Accounting Officer Sold 49,524 shares ($68.8K)
04 Feb 2026	Form 4: Burke Steven Keith, SVP, Chief Medical Officer Sold 67,658 shares ($94K)
04 Feb 2026	Form 4: Rucci Carolyn M., SVP, Chief Legal Officer Sold 69,772 shares ($97K)
04 Feb 2026	Form 4: Ostrowski Erik, SVP, CFO, CBO & Treasurer Sold 34,951 shares ($48.6K)
04 Feb 2026	Form 4: Butler John P., Director Sold 341,305 shares ($474K) · Received 175,250 shares as a grant or award ($247K)
03 Feb 2026	Form 4: Grund Nicholas, Chief Commercial Officer Received 204,000 shares as a grant or award · Granted 320,000 Stock Option (Right to buy)
03 Feb 2026	Form 4: Burke Steven Keith, SVP, Chief Medical Officer Received 204,000 shares as a grant or award · Granted 320,000 Stock Option (Right to buy)
03 Feb 2026	Form 4: Rucci Carolyn M., SVP, Chief Legal Officer Received 190,000 shares as a grant or award · Granted 270,000 Stock Option (Right to buy)
03 Feb 2026	Form 4: Malabre Richard C, SVP, Chief Accounting Officer Received 79,000 shares as a grant or award · Granted 119,000 Stock Option (Right to buy)

Comments